FOMAT

Nephrology

FOMAT Prime Therapeutic Areas provide highly specialized nephrology research sites with robust infrastructure, experienced investigators, and proven recruitment models. In Nephrology, we support studies in chronic kidney disease (CKD), acute kidney injury (AKI), diabetic nephropathy, hypertension related kidney damage, glomerulonephritis, and end stage renal disease (ESRD), backed by established patient relationships, strong enrollment performance, and consistent quality oversight across centers.
Patients in our nephrology database
0
Diversity enrollment target met
0 %
Retention achieved in a nephrology infusion study
0 %
Site in the world to enroll a patient in an IgA nephropathy trial in 2025
0 st

Nephrology trial capabilities

Our nephrology trial capabilities include integrated diagnostic and monitoring equipment, experienced clinical research teams, and reliable operational support. We enable consistent trial delivery through coordinated clinical operations and patient centered engagement.
  • Diagnostic and monitoring capabilities including renal ultrasound, Doppler studies, ECG, ambulatory blood pressure monitoring, point of care urinalysis, and weight monitoring
  • Research storage and processing capabilities including minus 20°C and minus 70°C freezers, centrifuges, central lab support, and dedicated drug and document storage areas
  • Integrated electronic systems including EHR, CTMS, eCRFs or eSource, eReg, and eConsent
  • Dedicated research spaces including waiting areas, consultation rooms, and examination rooms
  • Cross functional resourcing across clinical operations, community engagement, patient liaison specialists, and dedicated support teams in regulatory, finance, QC and QA, and start up
Nephrology | FOMAT

Key differentiators

Reliable start-up execution
Dedicated start up support across regulatory and operational functions to support predictable activation and coordinated delivery.
Experienced nephrology investigators
Board certified nephrology investigators with deep clinical and research experience, including CKD and IgA nephropathy focus, supporting diverse patient populations. 
Real time data and study operations enablement
Integrated platforms such as EHR, CTMS, eSource, eReg, and eConsent help support clean, timely workflows and sponsor ready documentation.
Strong recruitment and retention execution
Demonstrated enrollment performance with full retention in a nephrology infusion study, reflecting consistent patient engagement and well coordinated site operations.
Proven performance in nephrology studies
First site globally to enroll a patient in an IgA nephropathy trial in 2025, demonstrating swift activation capabilities and execution readiness.